metformin and fructose 2,6-diphosphate

metformin has been researched along with fructose 2,6-diphosphate in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Agius, L; Al-Oanzi, ZH; Alshawi, A; Arden, C; Fountana, S; Moonira, T; Patman, G; Petrie, JL; Reeves, HL; Tudhope, SJ1
Cai, Z; Liu, X; Lv, N; Yan, H; Zhang, E; Zhao, Y1

Other Studies

2 other study(ies) available for metformin and fructose 2,6-diphosphate

ArticleYear
Opposite effects of a glucokinase activator and metformin on glucose-regulated gene expression in hepatocytes.
    Diabetes, obesity & metabolism, 2017, Volume: 19, Issue:8

    Topics: Active Transport, Cell Nucleus; Animals; Basic Helix-Loop-Helix Leucine Zipper Transcription Factors; Cells, Cultured; Diet, Western; Enzyme Activators; Fructose; Fructosediphosphates; Gene Expression Regulation, Enzymologic; Glucokinase; Glucose-6-Phosphatase; Glucose-6-Phosphate; Hepatocytes; Hypoglycemic Agents; Male; Metformin; Mice, Inbred C3H; Overweight; Promoter Regions, Genetic; Pyruvate Kinase; Rats, Wistar; Thiazoles

2017
The synergistic effect of PFK15 with metformin exerts anti-myeloma activity via PFKFB3.
    Biochemical and biophysical research communications, 2019, 07-23, Volume: 515, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Drug Synergism; Enzyme Inhibitors; Fructosediphosphates; Glucose; Humans; Hypoglycemic Agents; Metformin; Multiple Myeloma; Phosphofructokinase-2; Pyridines; Quinolines; RNA, Messenger; Signal Transduction

2019